Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S N Routray

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of the Association of Physicians of India|June 25, 2023
Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from IndiaH K Chopra, G S Wander, Tiny Nair, et al.
The Journal of the Association of Physicians of India|June 24, 2023
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus StatementH K Chopra, G S Wander, C K Ponde, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney DiseaseH K Chopra, Dinesh Khullar, Tiny Nair, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Role of Bisoprolol in Heart Failure Management: A Consensus Statement from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
Indian Heart Journal|December 25, 2018
Corrigendum to "Cardiological Society of India position statement on management of heart failure in India" [Indian Heart J 70 (S1) (2018) S1-S72]Santanu Guha, S Harikrishnan, Saumitra Ray, et al.
Indian Heart Journal|August 21, 2018
CSI position statement on management of heart failure in IndiaSantanu Guha, S Harikrishnan, Saumitra Ray, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of the Association of Physicians of India|June 25, 2023
Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from IndiaH K Chopra, G S Wander, Tiny Nair, et al.
The Journal of the Association of Physicians of India|June 24, 2023
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus StatementH K Chopra, G S Wander, C K Ponde, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney DiseaseH K Chopra, Dinesh Khullar, Tiny Nair, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Role of Bisoprolol in Heart Failure Management: A Consensus Statement from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from IndiaH K Chopra, Tiny Nair, G S Wander, et al.
Indian Heart Journal|December 25, 2018
Corrigendum to "Cardiological Society of India position statement on management of heart failure in India" [Indian Heart J 70 (S1) (2018) S1-S72]Santanu Guha, S Harikrishnan, Saumitra Ray, et al.
Indian Heart Journal|August 21, 2018
CSI position statement on management of heart failure in IndiaSantanu Guha, S Harikrishnan, Saumitra Ray, et al.
Pageof 3